CIENCIASMEDICASNEWS: Researchers develop new gene therapy for congenital blindness

viernes, 2 de octubre de 2020

Researchers develop new gene therapy for congenital blindness

	Ophthalmology / Optometry
	The latest ophthalmology / optometry news from News Medical

Researchers develop new gene therapy for congenital blindness

Retinitis pigmentosa is the most prevalent form of congenital blindness. Using a retinitis pigmentosa mouse model, researchers from Ludwig-Maximilians Universitaet (LMU) in Munich have now shown that targeted activation of genes of similar function can compensate for the primary defect.

			Gene therapy to the inner retina prevents blindness in Cln3-deficient mice Gene therapy to the inner retina prevented blindness in a mouse model of the neuro-degenerative disorder CLN3 Batten disease.

			Scientists propose a promising new tool based on optogenetics to study neurons In many human endeavors, having good tools for a particular task is an essential requirement to obtain the best results possible, and neuroscience is no different than other scientific fields in this regard.

	A collaborative team to develop new treatment for age-related macular degeneration Karolinska Institutet and St. Erik Eye Hospital in Sweden have entered into a collaboration with Novo Nordisk A/S to develop a new treatment for age-related macular degeneration.

	New insight into how people with retinal degenerative disease can maintain night vision New insight on how people with retinal degenerative disease can maintain their night vision for a relatively long period of time has been published today in the open-access eLife journal.

	Multifocal contact lenses reduce worsening nearsightedness in children Children wearing multifocal contact lenses had slower progression of their myopia, according to results from a clinical trial funded by the National Eye Institute, part of the National Institutes of Health.

	New cell injection technique could help reverse forms of vision loss University of Toronto Engineering researchers have developed a new method of injecting healthy cells into damaged eyes.